Neurological Biomarkers Market Expected to Reach $18.9 Billion by 2031 | CAGR 13.6% 

Neurological biomarkers market size was valued at $5.4 billion in 2021, and is estimated to reach $18.9 billion by 2031, growing at a CAGR of 13.6% from 2022 to 2031.  Ever-increasing rise in the incidence of Alzheimer’s and Parkinson’s is anticipated to contribute toward the robust growth of neurological biomarkers among these two applications. In …

Neurological Biomarkers Market Growing at a CAGR of 10.1% | Forecast, 2018 to 2025

Neurological Biomarkers Market for Alzheimer’s and Parkinson’s Disease: Global Opportunity Analysis and Industry Forecast, 2017-2025. The global market was valued at $3,958.5 million in 2017 and is projected to reach $8,579.9 million by 2025, growing at a CAGR of 10.1% from 2018 to 2025. China accounted for one-ninth of the total market for neurological biomarkers …